{"title":"Influence of intraluminal stent placement on 18-month outcomes of Preserflo MicroShunt in Japanese patients with open-angle glaucoma.","authors":"Shunsuke Osaki, Yusaku Miura, Kenji Yamashiro","doi":"10.1007/s10384-026-01426-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy of the PreserFlo MicroShunt (PMS) at 18 months in Japanese patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (EXG) between eyes with preoperative intraocular pressure (IOP) < 15 mmHg (low-tension glaucoma [LTG] group) and ≥ 15 mmHg (high-tension glaucoma [HTG] group), and to evaluate the impact of intraluminal stent removal timing on postoperative surgical outcomes.</p><p><strong>Study design: </strong>Retrospective clinical investigation.</p><p><strong>Methods: </strong>Records of all POAG and EXG patients undergoing PMS at Kochi University Hospital (June 2023-June 2024) were reviewed. Eyes were categorized by preoperative IOP (LTG/HTG) and by stent use: no stent (NST), stent removal at days 1-7 (ST1), days 8-14 (ST2), and day 15 or later (ST3).</p><p><strong>Results: </strong>The study included 75 HTG and 49 LTG eyes. At 18 months, IOP decreased significantly in both HTG (20.5 ± 4.9 to 12.2 ± 3.3 mmHg, P < 0.001) and LTG groups (12.4 ± 1.8 to 10.9 ± 2.5 mmHg, P = 0.037). Medication scores decreased significantly in both groups (P < 0.001). Hypotony rates were lower in the ST2 (9.5%) and ST3 (16.3%) groups than in the NST (65.2%) and ST1 (38.7%) groups. Stent retention did not adversely affect IOP at 18 months.</p><p><strong>Conclusion: </strong>Although surgical success was significantly lower in LTG than in HTG, PMS significantly reduced IOP in Japanese patients with both POAG and EXG at 18 months. Additionally, retaining the intraluminal stent for more than 1 week reduced hypotony risk without adversely affecting postoperative IOP.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10384-026-01426-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To compare the efficacy of the PreserFlo MicroShunt (PMS) at 18 months in Japanese patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (EXG) between eyes with preoperative intraocular pressure (IOP) < 15 mmHg (low-tension glaucoma [LTG] group) and ≥ 15 mmHg (high-tension glaucoma [HTG] group), and to evaluate the impact of intraluminal stent removal timing on postoperative surgical outcomes.
Study design: Retrospective clinical investigation.
Methods: Records of all POAG and EXG patients undergoing PMS at Kochi University Hospital (June 2023-June 2024) were reviewed. Eyes were categorized by preoperative IOP (LTG/HTG) and by stent use: no stent (NST), stent removal at days 1-7 (ST1), days 8-14 (ST2), and day 15 or later (ST3).
Results: The study included 75 HTG and 49 LTG eyes. At 18 months, IOP decreased significantly in both HTG (20.5 ± 4.9 to 12.2 ± 3.3 mmHg, P < 0.001) and LTG groups (12.4 ± 1.8 to 10.9 ± 2.5 mmHg, P = 0.037). Medication scores decreased significantly in both groups (P < 0.001). Hypotony rates were lower in the ST2 (9.5%) and ST3 (16.3%) groups than in the NST (65.2%) and ST1 (38.7%) groups. Stent retention did not adversely affect IOP at 18 months.
Conclusion: Although surgical success was significantly lower in LTG than in HTG, PMS significantly reduced IOP in Japanese patients with both POAG and EXG at 18 months. Additionally, retaining the intraluminal stent for more than 1 week reduced hypotony risk without adversely affecting postoperative IOP.
期刊介绍:
The Japanese Journal of Ophthalmology (JJO) was inaugurated in 1957 as a quarterly journal published in English by the Ophthalmology Department of the University of Tokyo, with the aim of disseminating the achievements of Japanese ophthalmologists worldwide. JJO remains the only Japanese ophthalmology journal published in English. In 1997, the Japanese Ophthalmological Society assumed the responsibility for publishing the Japanese Journal of Ophthalmology as its official English-language publication.
Currently the journal is published bimonthly and accepts papers from authors worldwide. JJO has become an international interdisciplinary forum for the publication of basic science and clinical research papers.